Articles

Many molecularly targeted agents that inhibit different pathways of hepatocarcinogenesis are under clinical development, and novel targets are being assessed in hepatocellular carcinoma (HCC). Read More ›

Patients with terminal hepatocellular carcinoma (HCC) may be a poorly understood group, according to the findings of quality-of-life research conducted by Lissi Hansen, PhD, RN, of Oregon Health and Science University in Portland, whose special interests are end-of-life issues and ethics. Read More ›

Subsets of patients with colon cancer may benefit from increased surveillance for toxicities associated with adjuvant FOLFOX (leucovorin, fluorouracil, oxaliplatin) treatment, Canadian researchers suggest, based on their detailed analysis of the toxicity profile of this common regimen and their identification of factors that predict toxicity. They presented their findings at the 2014 Gastrointestinal Cancers Symposium, held January 16-18, in San Francisco, California. Read More ›

In 2010, Dr Thomas Frieden, director of the Centers for Disease Control and Prevention (CDC), chose the 6 original health priorities that he would call “winnable battles.” Read More ›

The optimal dosing of pomalidomide in the treatment of multiple myeloma has not been established. Yale University investigators compared continuous and intermittent dosing regimens, and while the intermittent schedule was associated with more toxicity, they concluded that it is preferable... Read More ›

Honesty is not always a bad thing: I am also the person who tells you that you have something in your teeth, yanks toilet paper off your foot, or pulls out that skirt, which you somehow tucked into your panty hose, before you leave the restroom. Read More ›

The St. Jude Crosson Comprehensive Cancer Center, located in Fullerton, California, is part of the St. Joseph Health System. The cancer center was established in 1998 and includes the Ann G. Fetters Diagnostic Imaging Center, the Fred A. Jordan Family Radiation Oncology Center, and the Kathryn T. McCarty Breast Center. Read More ›

In this issue of The Oncology Nurse-APN/PA (TON), we discuss some of the “personal” situations we may confront as healthcare professionals. Read More ›

May 5th is Melanoma Monday, as designated by the American Academy of Dermatology. Read More ›

As a 7-year breast cancer survivor, my primary feeling most of the time is awe and gratitude that I’m still here. I can savor life’s small moments and big events, from sipping a piping hot tall dark roast to celebrating my dear friend’s 50th by dancing my you-know-what off! Read More ›